Submission for Office of Management and Budget Review; Title V State Sexual Risk Avoidance Education (Office of Management and Budget #0970-0551), 66007-66008 [2023-20758]
Download as PDF
<![CDATA[
66007
Federal Register / Vol. 88, No. 185 / Tuesday, September 26, 2023 / Notices
Preliminary
amount
available for
reallotment 1
Name of grant recipient that has funds to be returned for reallotment
Seneca Nation of Indians ....................................................................................................................................................................
South Puget Intertribal Planning Agency ............................................................................................................................................
Spirit Lake Nation ................................................................................................................................................................................
Standing Rock Sioux Tribe ..................................................................................................................................................................
Thlopthlocco Tribal Town ....................................................................................................................................................................
Turtle Mountain Band of Chippewa Indians ........................................................................................................................................
United Keetoowah Band of Cherokee Indians ....................................................................................................................................
Ute Indian Tribe ...................................................................................................................................................................................
Yankton Sioux Tribe ............................................................................................................................................................................
20,244
739
287,077
396,242
9,446
2,376,042
272,128
1,672
244,986
Total ..............................................................................................................................................................................................
21,985,238
1 Preliminary funds for reallotment consist of the funds in excess of LIHEAP’s 10 percent carryover cap that (1) 73 recipients indicated on the
FFRs or reported on the CRRs as unobligated; or (2) amounted to 100 percent of regular funds or IIJA funds for the 3 recipients that failed to
submit the associated FFRs and their CRRs.
If funds are reallotted, then grant
recipients may use them for any
purpose authorized under LIHEAP and
must add these funds to their total
LIHEAP funds payable for FFY 2023 for
purposes of calculating statutory caps
on administrative costs, carryover,
Assurance 16 activities, and
weatherization assistance.
Additionally, all recipients of these
funds must (1) ensure that they are
included in the amounts on Lines 1.1 of
their FFY 2023 CRRs; (2) reconcile these
funds, to the extent that they received
them, on a separate FFR; and (3) record,
on their FFY 2023 Household Reports,
households that receive benefits at least
partly from these funds. State recipients
must also ensure that these funds are
included in the Grantee Survey sections
of their FFY 2023 LIHEAP Performance
Data Forms.
Statutory Authority: 42 U.S.C.
8626(b).
Karen D. Shields,
Senior Grants Policy Specialist, Office of
Grants Policy, Office of Administration.
[FR Doc. 2023–20788 Filed 9–25–23; 8:45 am]
BILLING CODE 4184–80–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
lotter on DSK11XQN23PROD with NOTICES1
Submission for Office of Management
and Budget Review; Title V State
Sexual Risk Avoidance Education
(Office of Management and Budget
#0970–0551)
Family and Youth Services
Bureau, Administration for Children
AGENCY:
VerDate Sep<11>2014
18:18 Sep 25, 2023
Jkt 259001
and Families, United States Department
of Health and Human Services.
ACTION: Request for public comments.
The Family and Youth
Services Bureau (FYSB) within the
Administration on Children, Youth and
Families (ACYF) is accepting mandatory
formula grant applications and State
plans from States and Territories for the
development of and implementation for
Title V State Sexual Risk Avoidance
Education (SRAE) Program. The Title V
State SRAE Notice of Funding
Opportunity (NOFO) sets forth the
application requirements for recipients.
This request is to extend Office of
Management and Budget (OMB)
approval of the request for information.
No changes are proposed.
DATES: Comments due within 30 days of
publication. OMB must make a decision
about the collection of information
between 30 and 60 days after
publication of this document in the
Federal Register. Therefore, a comment
is best assured of having its full effect
if OMB receives it within 30 days of
publication.
ADDRESSES: Written comments and
recommendations for the proposed
information collection should be sent
within 30 days of publication of this
notice to www.reginfo.gov/public/do/
PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function. You can also obtain
copies of the proposed collection of
information by emailing infocollection@
acf.hhs.gov. Identify all emailed
requests by the title of the information
collection.
SUMMARY:
PO 00000
Frm 00062
Fmt 4703
Sfmt 4703
The Title
V SRAE Program has mandatory,
formula allotments for State and
Territories to apply. The application
process is for States and Territories to
submit and for ACYF/FYSB to collect an
application, State plan, and semi-annual
performance progress reports.
SUPPLEMENTARY INFORMATION:
Purpose and Use of the Information
Collection
The application and State plans will
offer information about the proposed
State project and it will be used as the
primary basis to determine whether or
not the project meets the minimum
requirements of the NOFO for the grant
award.
The Performance Progress Reports are
collected semi-annually and will inform
the monitoring of the grantees’ program
design, program evaluation,
management improvement, service
quality and compliance with agreed
upon goals. ACYF/FYSB will use the
information to assure effective service
delivery for program participants.
Finally, the data from this collection
will be used to report outcomes and
efficiencies and will provide valuable
information to policy makers and key
stakeholders in the development of
program and research efforts.
Respondents: Thirty-eight States and
nine Territories, to include, District of
Columbia, Puerto Rico, Virgin Islands,
Guam, American Samoa, Northern
Mariana Islands, the Federated States of
Micronesia, the Marshall Islands, and
Palau.
E:\FR\FM\26SEN1.SGM
26SEN1
66008
Federal Register / Vol. 88, No. 185 / Tuesday, September 26, 2023 / Notices
ANNUAL BURDEN ESTIMATES
Instrument
Total number
of respondents
Annual
number of
responses per
respondent
47
47
47
1
1
2
Applications ......................................................................................................
State Plans ......................................................................................................
Performance Progress Reports .......................................................................
Estimated Total Annual Burden
Hours: 4,512.
Authority: Section 510 of the Social
Security Act (42 U.S.C. 710), as
amended by section 50502 of the
Bipartisan Budget Act of 2018 (Pub. L.
115–123) and extended by Division CC,
title III, section 303 of the Consolidated
Appropriations Act, 2022 (Pub. L. 117–
103).
Mary B. Jones,
ACF/OPRE Certifying Officer.
[FR Doc. 2023–20758 Filed 9–25–23; 8:45 am]
BILLING CODE 4184–83–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2023–N–0001]
Advancing the Development of
Pediatric Therapeutics on Drug Dosing
in Pediatric Patients With Renal
Impairment; Public Workshop
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice of public workshop.
The Food and Drug
Administration (FDA, the Agency, or
we) is announcing the following public
workshop entitled ‘‘Advancing the
Development of Pediatric Therapeutics
(ADEPT 8) on Drug Dosing in Pediatric
Patients With Renal Impairment.’’ The
purpose of the public workshop is to
discuss the current landscape of drug
dosing in pediatric patients with renal
impairment, understand the gaps in
knowledge, and consider innovative
approaches to improve the current
paradigm for dosing in pediatric
patients with renal impairment.
DATES: The public workshop will be
held on November 30, 2023, and
December 1, 2023, from 9 a.m. to 5 p.m.
eastern time each day. See the
SUPPLEMENTARY INFORMATION section for
registration date and information.
ADDRESSES: The public workshop will
be held at the FDA White Oak Campus
Great Room and online. Entrance for the
registered public workshop participants
(non-FDA employees) is through
lotter on DSK11XQN23PROD with NOTICES1
SUMMARY:
VerDate Sep<11>2014
18:18 Sep 25, 2023
Jkt 259001
Building 1 where routine security check
procedures will be performed. For
parking and security information, please
refer to https://www.fda.gov/about-fda/
visitor-information.
FOR FURTHER INFORMATION CONTACT: Julie
Levin, Office of New Drugs Public
Meeting Support, Food and Drug
Administration, 10903 New Hampshire
Ave., Bldg. 22, Rm. 6481, Silver Spring,
MD 20993–0002, 202–567–7565,
ONDPublicMTGSupport@fda.hhs.gov.
SUPPLEMENTARY INFORMATION:
I. Background
The pharmacokinetics of drugs
excreted by the kidneys may be altered
by renal (kidney) impairment, requiring
dosing adjustments. However, the
majority of drugs that are predominantly
renally excreted and have dosage
recommendations for adults with renal
impairment lack dose adjustment
recommendations for pediatric patients
with renal impairment. This is largely
due to the lack of generation of
pharmacokinetic data in pediatric
patients with renal impairment, which
is attributable to both the ethical and the
practical limitations of conducting
dedicated renal impairment studies in
pediatric patients, as well as the
exclusion of pediatric patients with
renal impairment from most clinical
efficacy and safety studies. For drugs
that are renally cleared, exposures can
be impacted by both the maturation of
kidney function and the renal
impairment due to kidney disease.
II. Topics for Discussion at the Public
Workshop
The main objective of the ‘‘Advancing
the Development of Pediatric
Therapeutics (ADEPT 8) on Drug Dosing
in Pediatric Patients With Renal
Impairment’’ workshop is to discuss
current approaches to classifying renal
impairment in the pediatric population,
identify data gaps, and explore
scientifically supported approaches and
methods for providing information on
dosing adjustment. The workshop will
specifically focus on measurements of
renal function, extrapolation of adult
data, and approaches to generating
clinical trial data to assess the impact of
PO 00000
Frm 00063
Fmt 4703
Sfmt 4703
Average
burden hours
per response
Annual
burden hours
24
40
16
1,128
1,880
1,504
renal impairment on the
pharmacokinetics of drugs in pediatric
patients. In addition, the workshop will
allow for an open dialogue around the
use of these approaches among
regulators, industry, academia, and
patient organizations.
III. Participating in the Public
Workshop
Registration: To register for the public
workshop, please visit the following
website: https://www.eventbrite.com/e/
adept-8-pediatric-renal-impairmentworkshop-tickets-687423571407. Please
provide complete contact information
for each attendee, including name, title,
affiliation, address, email, and
telephone.
Registration is free and based on
space availability, with priority given to
early registrants. Persons interested in
attending this public workshop must
register by November 15, 2023, 11:59
p.m. Eastern Time. Early registration is
recommended because seating is
limited; therefore, FDA may limit the
number of participants from each
organization. Registrants will receive
confirmation when they have been
accepted.
If you need special accommodations
due to a disability, please contact Julie
Levin at ONDPublicMTGSupport@
fda.hhs.gov no later than November 15,
2023.
Streaming Webcast of the Public
Workshop: This public workshop will
also be via Zoom. A link will be
provided via email to registered
participants. If you have never attended
a Zoom event before, test your internet
connection by joining a test meeting at
https://zoom.us/test. FDA has verified
the website addresses in this document,
as of the date this document is
published in the Federal Register, but
websites are subject to change over time.
Transcripts: Please be advised that
when a transcript of the public
workshop is available, it will be
accessible at https://
www.regulations.gov. It may be viewed
at the Dockets Management Staff (HFA–
305), Food and Drug Administration,
5630 Fishers Lane, Rm. 1061, Rockville,
MD 20852.
E:\FR\FM\26SEN1.SGM
26SEN1
]]>Agencies
[Federal Register Volume 88, Number 185 (Tuesday, September 26, 2023)]
[Notices]
[Pages 66007-66008]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-20758]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Administration for Children and Families
Submission for Office of Management and Budget Review; Title V
State Sexual Risk Avoidance Education (Office of Management and Budget
#0970-0551)
AGENCY: Family and Youth Services Bureau, Administration for Children
and Families, United States Department of Health and Human Services.
ACTION: Request for public comments.
-----------------------------------------------------------------------
SUMMARY: The Family and Youth Services Bureau (FYSB) within the
Administration on Children, Youth and Families (ACYF) is accepting
mandatory formula grant applications and State plans from States and
Territories for the development of and implementation for Title V State
Sexual Risk Avoidance Education (SRAE) Program. The Title V State SRAE
Notice of Funding Opportunity (NOFO) sets forth the application
requirements for recipients. This request is to extend Office of
Management and Budget (OMB) approval of the request for information. No
changes are proposed.
DATES: Comments due within 30 days of publication. OMB must make a
decision about the collection of information between 30 and 60 days
after publication of this document in the Federal Register. Therefore,
a comment is best assured of having its full effect if OMB receives it
within 30 days of publication.
ADDRESSES: Written comments and recommendations for the proposed
information collection should be sent within 30 days of publication of
this notice to www.reginfo.gov/public/do/PRAMain. Find this particular
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function. You can
also obtain copies of the proposed collection of information by
emailing [email protected]. Identify all emailed requests by
the title of the information collection.
SUPPLEMENTARY INFORMATION: The Title V SRAE Program has mandatory,
formula allotments for State and Territories to apply. The application
process is for States and Territories to submit and for ACYF/FYSB to
collect an application, State plan, and semi-annual performance
progress reports.
Purpose and Use of the Information Collection
The application and State plans will offer information about the
proposed State project and it will be used as the primary basis to
determine whether or not the project meets the minimum requirements of
the NOFO for the grant award.
The Performance Progress Reports are collected semi-annually and
will inform the monitoring of the grantees' program design, program
evaluation, management improvement, service quality and compliance with
agreed upon goals. ACYF/FYSB will use the information to assure
effective service delivery for program participants. Finally, the data
from this collection will be used to report outcomes and efficiencies
and will provide valuable information to policy makers and key
stakeholders in the development of program and research efforts.
Respondents: Thirty-eight States and nine Territories, to include,
District of Columbia, Puerto Rico, Virgin Islands, Guam, American
Samoa, Northern Mariana Islands, the Federated States of Micronesia,
the Marshall Islands, and Palau.
[[Page 66008]]
Annual Burden Estimates
----------------------------------------------------------------------------------------------------------------
Annual number Average burden
Instrument Total number of responses hours per Annual burden
of respondents per respondent response hours
----------------------------------------------------------------------------------------------------------------
Applications.................................... 47 1 24 1,128
State Plans..................................... 47 1 40 1,880
Performance Progress Reports.................... 47 2 16 1,504
----------------------------------------------------------------------------------------------------------------
Estimated Total Annual Burden Hours: 4,512.
Authority: Section 510 of the Social Security Act (42 U.S.C. 710),
as amended by section 50502 of the Bipartisan Budget Act of 2018 (Pub.
L. 115-123) and extended by Division CC, title III, section 303 of the
Consolidated Appropriations Act, 2022 (Pub. L. 117-103).
Mary B. Jones,
ACF/OPRE Certifying Officer.
[FR Doc. 2023-20758 Filed 9-25-23; 8:45 am]
BILLING CODE 4184-83-P
